Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients

Karachaliou et al. (Mon,) studied this question.

www.synapsesocial.com/papers/69df2c59de200760a86149a6 — DOI: https://doi.org/10.1177/1758834017749748

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Progenitor and Terminal Subsets of CD8 ⁺ T Cells Cooperate to Contain Chronic Viral Infection· 2012 · 886 citations
2. Tumor immune microenvironment characterization and response to anti-PD-1 therapy· 2015 · 59 citations
3. Anti-CTLA-4 therapy results in higher CD4 ⁺ ICOS ^hi T cell frequency and IFN-γ levels in both nonmalignant and malignant prostate tissues· 2009 · 216 citations
4. Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome· 2016 · 223 citations
5. Correction: Preventing tumor escape by targeting a post-proteasomal trimming independent epitope· 2017 · 3 citations